G
GH
Guardant Health
78.60
-8.57-9.83%After Hours: 79.00 +0.40 +0.51%19:38 04/10 EDT
OPEN/PREV CLOSE87.11/87.17
TODAY RANGE74.55-88.41
VOL6.41M
MARKET CAP10.31B
52 WEEK RANGE36.36-120.74
AVG VOL (3M)2.01M
% TURNOVER4.88%
TURNOVER--
P/E (TTM)-23.6726
% RANGE15.89%
EPS(TTM)-3.3203
P/E(FORWARD)-26.8718
P/B-103.3938
BVPS-0.7602
DIVIDEND--
P/S10.46
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP9.88B
SHARES OUTSTANDING131.17M
NEXT EARNINGS04/28-05/04
FREE FLOAT125.68M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·3d ago
Should Guardant Health’s (GH) Role in ENHERTU’s Japan Approval Require Action From Investors?
TipRanks·4d ago
Citi adds ‘upside 90-day catalyst watch’ on Guardant Health
Seeking Alpha·4d ago
Guardant Health: Leveraging Liquid Biopsy Testing Momentum
Simply Wall St·6d ago
Guardant Health (GH) Valuation After Japan ENHERTU Approval Backed By InfinityAI Real World Evidence
Barchart·03/31 14:22
Why Is Guardant Health (GH) Stock Soaring Today
Simply Wall St·03/31 01:43
The Bull Case For Guardant Health (GH) Could Change Following Japan’s ENHERTU Approval Using Its AI Data
TipRanks·03/30 12:37
Guardant Health announces evidence generated from InfinityAI
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.